CMAC 2003; 5(4) | CMAC

CMAC 2003; 5(4)

The document was approved by International Society of Chemotherapy (ISC), Surgical Infection Society Europe (SISE), Interregional …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):302-317
PDF

The objective of this prospective multicentre study was to evaluate the efficacy of cefoperazone/sulbactam for monotherapy of patients …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):318-328
PDF

Whooping cough remains a significant problem worldwide, even in countries with high number of immunized people. However, a lack of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):329-341
PDF

Invasive mycoses becoming more and more important problem of the modern medicine that is reflecting the increasing number of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):342-353
PDF

The aim of this study was to review published data on efficacy and safety of prophylaxis and empirical therapy with antifungals in …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):354-359
PDF

Antiretroviral drugs today are the basis of HIV therapy. The severe and progressive nature of the disease and the need for lifelong …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):360-379
PDF

Сommunity-acquired pneumonia remains one of the most common infections in population, and despite the wide array of antimicrobials, it …
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):380-388
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):389-392
PDF